Literature DB >> 3957548

Natural immunity to measles, rubella and mumps among Spanish children in the pre-vaccination era.

M Arroyo, J M Alia, M L Mateos, J L Carrasco, F Ballesteros, R Lardinois.   

Abstract

Prior to the start of mass vaccination campaigns against measles, rubella and mumps, a prevalence study of natural immunity to these diseases was undertaken in a sample of 1700 unvaccinated Spanish children. They were representative of the 3-7 year-old population in terms of age, regional distribution and urban or rural environment. Measles infection prevalence was significantly higher than that for rubella and mumps from 3 (48.3%, 14.2%, 25.5%, respectively) through 7 years of age, (64%, 40.9%, 39%). As a function of age, naturally-acquired immunity increased according to parabolic progressions. In the 3-5 year-old group, rural environment, low socioeconomic status, no school attendance and lack of brothers were associated with statistically lower levels of measles, rubella, or mumps infection. In the 6-7 year-old group, only 12% of the children showed antibodies against the three diseases and 18.7% exhibited triple susceptibility.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3957548     DOI: 10.1093/ije/15.1.95

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  3 in total

1.  Seroepidemiology of measles in Catalonia (Spain) 1985-1986.

Authors:  L Salleras; J Vidal; J Canela; M T Jimenez De Anta; T Pumarola; J J Coll; M L De La Puente; L Serra
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

2.  Viral etiology of mumps-like illnesses in suspected mumps cases reported in Catalonia, Spain.

Authors:  Irene Barrabeig; Josep Costa; Ariadna Rovira; M Angeles Marcos; Ricard Isanta; Rubén López-Adalid; Ana Cervilla; Nuria Torner; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  Sero-survey of rubella IgM antibodies among children in Jos, Nigeria.

Authors:  Surajudeen A Junaid; King J Akpan; Atanda O Olabode
Journal:  Virol J       Date:  2011-05-19       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.